DD143075A5 - Verfahren zur herstellung von 4-desacetyl-vincaleucoblastin-c tief 3-carbonsaeurehydraziden - Google Patents

Verfahren zur herstellung von 4-desacetyl-vincaleucoblastin-c tief 3-carbonsaeurehydraziden Download PDF

Info

Publication number
DD143075A5
DD143075A5 DD79212369A DD21236979A DD143075A5 DD 143075 A5 DD143075 A5 DD 143075A5 DD 79212369 A DD79212369 A DD 79212369A DD 21236979 A DD21236979 A DD 21236979A DD 143075 A5 DD143075 A5 DD 143075A5
Authority
DD
German Democratic Republic
Prior art keywords
vlb
deacetyl
reacted
item
carboxy
Prior art date
Application number
DD79212369A
Other languages
German (de)
English (en)
Inventor
George J Cullinan
Koert Gerzon
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD143075A5 publication Critical patent/DD143075A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DD79212369A 1978-04-20 1979-04-20 Verfahren zur herstellung von 4-desacetyl-vincaleucoblastin-c tief 3-carbonsaeurehydraziden DD143075A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/899,032 US4166810A (en) 1978-04-20 1978-04-20 Derivatives of 4-desacetyl VLB C-3 carboxyhydrazide

Publications (1)

Publication Number Publication Date
DD143075A5 true DD143075A5 (de) 1980-07-30

Family

ID=25410402

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79212369A DD143075A5 (de) 1978-04-20 1979-04-20 Verfahren zur herstellung von 4-desacetyl-vincaleucoblastin-c tief 3-carbonsaeurehydraziden

Country Status (32)

Country Link
US (1) US4166810A (bg)
EP (1) EP0005051B1 (bg)
JP (1) JPS54141798A (bg)
AR (1) AR228940A1 (bg)
AT (1) AT369010B (bg)
AU (1) AU527109B2 (bg)
BE (1) BE875652A (bg)
BG (3) BG33297A3 (bg)
CA (1) CA1097629A (bg)
CH (1) CH643269A5 (bg)
CS (3) CS218584B2 (bg)
DD (1) DD143075A5 (bg)
DE (1) DE2964130D1 (bg)
DK (1) DK147484C (bg)
EG (1) EG14867A (bg)
ES (2) ES479753A1 (bg)
FI (1) FI791286A (bg)
FR (1) FR2423495A1 (bg)
GB (1) GB2019396B (bg)
GR (1) GR69987B (bg)
HU (1) HU181431B (bg)
IE (1) IE48213B1 (bg)
IL (1) IL57168A (bg)
LU (1) LU81166A1 (bg)
NZ (1) NZ190213A (bg)
PH (1) PH14163A (bg)
PL (3) PL119416B1 (bg)
PT (1) PT69496A (bg)
RO (3) RO81114A (bg)
SU (3) SU893135A3 (bg)
YU (1) YU93179A (bg)
ZA (1) ZA791856B (bg)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322351A (en) * 1980-08-25 1982-03-30 Eli Lilly And Company Antineoplastic 4'-formylamino and 4'-acetylamino VLB, and derivatives thereof
EP0123441B1 (en) * 1983-03-30 1990-10-03 Lilly Industries Limited Vincaleukoblastine derivatives
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
US4667030A (en) * 1985-06-17 1987-05-19 Eli Lilly And Company Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids
US4801688A (en) * 1986-05-27 1989-01-31 Eli Lilly And Company Hydrazone immunoglobulin conjugates
US5043336A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Cyclic imide derivatives of 4-desacetyl VLB c-3 carboxhydrazide
US5043340A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Derivatives of 4-desacetyl VLB C-3 carboxhydrazide
EP1389209B1 (en) * 2001-04-24 2009-04-08 Purdue Research Foundation Folate mimetics and folate-receptor binding conjugates thereof
KR20040106547A (ko) * 2002-05-15 2004-12-17 엔도사이트, 인코포레이티드 비타민-마이토마이신 공액체
NZ541846A (en) 2003-01-27 2008-12-24 Endocyte Inc Vitamin receptor binding drug delivery conjugates
JP5149620B2 (ja) 2004-07-23 2013-02-20 エンドサイト，インコーポレイテッド ２価リンカーおよびその結合体
CN101175757B (zh) * 2005-03-16 2012-11-14 恩多塞特公司 蝶酸及其缀合物的合成和纯化
BRPI0615354A2 (pt) 2005-08-19 2011-05-17 Endocyte Inc conjugado de liberação de fármaco de ligação de receptor, composição farmacêutica que o compreende, bem como seu uso
EP2382995A3 (en) 2005-08-19 2013-09-25 Endocyte, Inc. Ligand conjugates of Vinca alkaloids, analogs and derivatives
WO2008100591A2 (en) * 2007-02-14 2008-08-21 The General Hospital Corporation Modulation of nitric oxide signaling to normalize tumor vasculature
US20100104626A1 (en) 2007-02-16 2010-04-29 Endocyte, Inc. Methods and compositions for treating and diagnosing kidney disease
NZ599239A (en) * 2007-03-14 2013-10-25 Endocyte Inc Binding ligand linked drug delivery conjugates of tubulysins
WO2009002993A1 (en) 2007-06-25 2008-12-31 Endocyte, Inc. Conjugates containing hydrophilic spacer linkers
US9877965B2 (en) 2007-06-25 2018-01-30 Endocyte, Inc. Vitamin receptor drug delivery conjugates for treating inflammation
US9187521B2 (en) * 2007-10-25 2015-11-17 Endocyte, Inc. Tubulysins and processes for preparing
EP2476414B1 (en) * 2009-09-07 2015-03-04 NIPRO Patch Co., Ltd. Transdermally absorbable preparation
US10080805B2 (en) 2012-02-24 2018-09-25 Purdue Research Foundation Cholecystokinin B receptor targeting for imaging and therapy
US20140080175A1 (en) 2012-03-29 2014-03-20 Endocyte, Inc. Processes for preparing tubulysin derivatives and conjugates thereof
IN2015DN04147A (bg) 2012-10-16 2015-10-16 Endocyte Inc

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine
US3205220A (en) * 1961-10-26 1965-09-07 Lilly Co Eli Leurosidine and leurocristine and their production
US3392173A (en) * 1964-03-09 1968-07-09 Lilly Co Eli Novel acyl derivatives of desacetyl-vincaleukoblastine and processes for their preparation
US3370057A (en) * 1964-04-27 1968-02-20 Lilly Co Eli Leurosine
US3387001A (en) * 1964-10-19 1968-06-04 Lilly Co Eli Novel aminoacyl esters of desacetyl vincaleukoblastine
US3887565A (en) * 1974-05-06 1975-06-03 Lilly Co Eli Vincadioline
US3890325A (en) * 1974-05-15 1975-06-17 Lilly Co Eli Leurocolombine
US3954773A (en) * 1974-11-21 1976-05-04 Eli Lilly And Company 4-Desacetoxyvinblastine
IL48685A (en) 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
US3944554A (en) * 1975-01-09 1976-03-16 Eli Lilly And Company 4-Desacetoxy-3-hydroxyvinblastine
US4029663A (en) * 1975-07-10 1977-06-14 Eli Lilly And Company Dimeric anhydro-vinca derivatives
US4115388A (en) * 1977-03-30 1978-09-19 Eli Lilly And Company 3'-Oxygenated derivatives of 4'-deoxy VLB "A" and "B" and related 1-formyl compounds

Also Published As

Publication number Publication date
IE790795L (en) 1979-10-20
IL57168A0 (en) 1979-07-25
PL215911A1 (bg) 1980-03-24
SU1061698A3 (ru) 1983-12-15
DK147484C (da) 1985-03-25
ES479753A1 (es) 1980-08-16
ZA791856B (en) 1980-11-26
AU4609779A (en) 1979-10-25
BG33296A3 (en) 1983-01-14
RO81037A (ro) 1983-02-01
FI791286A (fi) 1979-10-21
PL125470B1 (en) 1983-05-31
RO80084B (ro) 1983-01-30
CA1097629A (en) 1981-03-17
CS218584B2 (en) 1983-02-25
BG33297A3 (en) 1983-01-14
YU93179A (en) 1983-01-21
SU1225490A3 (ru) 1986-04-15
GB2019396B (en) 1982-09-15
PH14163A (en) 1981-03-19
HU181431B (en) 1983-07-28
AU527109B2 (en) 1983-02-17
NZ190213A (en) 1982-12-21
RO81114A (ro) 1983-02-01
EP0005051A1 (en) 1979-10-31
AT369010B (de) 1982-11-25
ATA291279A (de) 1982-04-15
CS218585B2 (en) 1983-02-25
EP0005051B1 (en) 1982-12-01
DK147484B (da) 1984-08-27
JPS6245873B2 (bg) 1987-09-29
RO81037B (ro) 1983-01-30
CS218583B2 (en) 1983-02-25
FR2423495A1 (fr) 1979-11-16
FR2423495B1 (bg) 1983-02-11
IE48213B1 (en) 1984-10-31
CH643269A5 (fr) 1984-05-30
JPS54141798A (en) 1979-11-05
PL119416B1 (en) 1981-12-31
EG14867A (en) 1986-09-30
LU81166A1 (fr) 1979-09-07
BE875652A (fr) 1979-10-18
DE2964130D1 (en) 1983-01-05
DK160679A (da) 1979-10-21
ES479754A1 (es) 1980-08-16
GB2019396A (en) 1979-10-31
RO80084A (ro) 1983-02-01
PT69496A (en) 1979-05-01
AR228940A1 (es) 1983-05-13
SU893135A3 (ru) 1981-12-23
BG33294A3 (bg) 1983-01-14
IL57168A (en) 1983-10-31
RO81114B (ro) 1983-01-30
US4166810A (en) 1979-09-04
GR69987B (bg) 1982-07-22

Similar Documents

Publication Publication Date Title
DD143075A5 (de) Verfahren zur herstellung von 4-desacetyl-vincaleucoblastin-c tief 3-carbonsaeurehydraziden
DE2415980C2 (bg)
DE2558124C2 (bg)
DE10230917A1 (de) Fredericamycin-Derivate
CH625530A5 (bg)
DE19547958B4 (de) Anthracyclin-Derivate
DE2347576C2 (de) Bruceantin und diese Verbindung enthaltende antileukämische Mittel
CH624962A5 (en) Process for the preparation of novel amide derivatives of dimeric vinblastin alkaloids
DE60012750T2 (de) Neue xanthon derivate, deren herstellung und verwendung als arzneimittel
AT390958B (de) Verfahren zur herstellung neuer bisindolalkaloidderivate
DE2739443A1 (de) Dimere indol-dihydroindolcarboxamide, verfahren zu ihrer herstellung und ihre verwendung
DE2753791C2 (bg)
DE2831579A1 (de) Anthracyclinglykoside
AT377764B (de) Verfahren zur herstellung von neuen 4-desacetyl-vincaleucoblastin-c3carbons|urehydraziden
AT377765B (de) Verfahren zur herstellung von neuen 4-desacetyl-vincaleucoblastin-c3carbons|urehydraziden
CH619465A5 (bg)
CH634849A5 (de) In 3'-stellung oxygenierte derivate von 4'-desoxy-vincaleukoblastin ''a'' und ''b'' sowie verwandte 1-formylverbindungen.
CH630061A5 (en) Process for the preparation of an antibiotic derivative
AT345996B (de) Verfahren zur herstellung neuer amidderivate von vinblastin, leurosidin und leurocristin und ihrer saeureadditionssalze
DD143618A5 (de) Verfahren zur herstellung von dimeren vincaalkaloiden
CH648321A5 (de) Cytostatisch wirksame verbindungen, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel.
DE2656678C2 (de) 4-Amino-trans-decahydrochinolin-Derivate und Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2221939B2 (de) 2-(3-Pyridazinyl)-3-(4-methylpiperazino-carbonyloxy)-1-isoindolinonderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2801748A1 (de) Dimere indoldihydroindole, verfahren zu ihrer herstellung und ihre verwendung
DD157558A5 (de) Verfahren zur herstellung von(vlb-oder 4-desacetyl-vlb)-3-(2-chlorethyl)-carboxamid